IMVT
Immunovant Inc
34.00$
-1.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 80.2% | 99.7% | 99.2% | 99.5% | 99.6% | 99.9% | 98.9% | 99.1% | |
| – | 80.2% | 91.9% | 97.0% | 95.8% | 92.8% | 95.3% | 92.0% | 94.2% | |
| – | 80.2% | 91.9% | 97.0% | 95.8% | 92.8% | 95.3% | 92.0% | 94.2% | |
| – | 731.4% | 2.8% | 0.3% | 2.5% | 0.2% | 0.8% | 0.3% | 0.4% | |
| – | – | – | 0.0% | 0.0% | 0.0% | -3.7% | – | – | |
| – | 13.3% | 0.1% | 0.0% | 0.1% | 0.1% | – | – | – | |
| 1,422.5% | 93.9% | 14.0% | 5.1% | 8.9% | 10.7% | 7.3% | 8.9% | 11.0% | |
| 1,422.5% | 93.9% | 14.0% | 4.6% | 8.6% | 10.7% | 7.3% | 8.9% | 10.9% | |
| – | 74.1% | 2.9% | 0.3% | 0.2% | 0.3% | 0.0% | 0.0% | 0.0% | |
| 1,003.7% | 0.1% | 1.1% | 0.6% | 3.6% | 0.3% | 1.1% | 2.3% | 0.8% | |
| -1,322.5% | 6.1% | 86.0% | 94.9% | 91.1% | 89.3% | 92.7% | 91.1% | 89.0% | |
| – | -0.1% | -83.4% | -48.2% | -68.9% | -139.6% | -123.8% | -159.7% | -182.2% | |
| 8,836.3% | 3,549.4% | 39.5% | 21.3% | 21.3% | 30.3% | 20.7% | 19.5% | 19.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.